News

The Latvian Medicines Verification Organization (LZVO) in the third issue of the Newsletter (October 2022) informs about system news, the cycle of seminars held, LZVS performance indicators in the third quarter of 2022 and analyse received alerts in the system.

The European Medicines Verification Organization (EMVO) has launched a newsletter, which informs about the National Medicines Verification Organization (NMVO) and the European Change Control Board (EU CCB) created by the EMVO, various working groups – IT, quality, as well as the Inter-Operability Testing group, which allows for more efficient management of the medicines verification system and improvement of its development in all Member States.

The Latvian Medicines Verification Organization (LZVO) in the second issue of the Newsletter (July 2022) informs about system news, the planned informative events in autumn, LZVS performance indicators in the first half of 2022 and analyse received alerts in the system.

The European Commission has published a new version of the Questions & Answers (Q&A) document on “Safety Features for Medicinal Products for Human Use (V.20)”.

EMVO Community Newsletter June 2022 you will find an overview of the latest developments and activities in our community, starting with a deep dive into the end of the stabilisation period in Ireland and finishing off with a summary of the best practices on Product Code Unknown (A1).

We are now reaching out to our customers and partners with a new informative material – the LZVO Newsletter. From now on, we will offer the most important information on the activities of LZVO and the Latvian Medicines Verification System (LZVS) in a short and summarised form on a quarterly basis.